ArticleSchizophrenia research. Cognition2025

The efficacy and safety of dual-target rTMS over dorsolateral prefrontal cortex (DLPFC) and cerebellum in the treatment of negative symptoms in first-episode schizophrenia: Protocol for a multicenter, randomized, double-blind, sham-controlled study.

Junjie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.